About 

Universe Pharmaceuticals Azioni (NASDAQ: UPC)

Ultime notizie per Universe Pharmaceuticals (NASDAQ:UPC) Azioni

Universe Pharmaceuticals

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals Inc

UNI-PRESIDENT C/H UNS/ADR by Uni-President China Holdings Ltd.

Uni-President China Holdings Ltd

UNIVERSAL POTASH CORP by Universal Potash Corp.

Universal Potash Corp

Precision Drilling (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PD#TSX">PD</a>) reported quarterly earnings of $2.20 per share which beat the analyst consensus estimate of $2.09 by 5.26 percent. This is a 13.04 percent decrease over earnings of $2.53 per share from the same period last year. The company reported quarterly sales of $496.33 million which missed the analyst consensus estimate of $499.91 million by 0.72 percent. This is a 5.96 percent decrease over sales of $527.79 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

TSX:PD

Precision Drilling Q1 EPS $2.20 Beats $2.09 Estimate, Sales $496.33M Miss $499.91M Estimate

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is still one of Wall Street&#8217;s most-watched names, but now it&#8217;s less about innovation and more about crash landings — figuratively speaking. 
With the stock off 33% year-to-date, investors are picking through the wreckage, trying to discern what comes next. A number of <a href="https://www.benzinga.com/etfs">ETFs with major Tesla exposure</a> have been in the hot seat lately, some expecting a bounce, others preparing for more bruises.
Simplify Volt TSLA Revolution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TESL#NYSE">TESL</a>) is arguably the most Tesla-heavy of them all, with a 54% weightage. It actively manages Tesla volatility through options overlays — imagine a high-risk Tesla with a parachute. Whether that parachute deploys in time is anyone&#8217;s guess.
Nightview Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NITE#NYSE">NITE</a>) contains a Tesla weighting of 18.4%, ranking as one of the most exposed to Tesla of all the mainstream funds. For holders of this ETF, headlines on Tesla are more than mere news, these are portfolio-forming events.
Vanguard Consumer Discretionary ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCR#NYSE">VCR</a>) isn&#8217;t far behind either, with Tesla contributing 13.3% to its portfolio.
As the stock plunges further and Wall Street analysts cut price targets in anticipation of every earnings season, these ETFs are traversing a rather Musk-ified market risk, one part fundamentals, one part drama.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44957724/tesla-stock-faces-demand-political-tariff-pressure-why-analysts-focus-on-multiple-generational-growth-drivers">Tesla Stock Faces Demand, Political, Tariff Pressure: Why Analysts Focus On &#8216;Multiple Generational Growth Drivers&#8217;</a>
<h1 class="wp-block-heading">Tariffs, Trouble &amp; Tesla&#8217;s Energy Mirage</h1>
Below the stock chart and into the details, Tesla&#8217;s most recent earnings report was a mixed bag. One welcome silver lining? The company&#8217;s energy and storage division, which reported $2.7 billion in revenue, up 67% from last year, with gross profit up a healthy 82%. But the celebration was short-lived.
<a href="https://www.benzinga.com/25/04/44942968/teslas-energy-business-carried-q1now-tariffs-could-kill-the-momentum-as-cfo-says-the-impact-will-be-outsized">CFO Vaibhav Taneja also identified a huge threat</a>: the <a href="https://www.benzinga.com/topic/tariffs">tariff headwinds</a> that endanger the segment. &#8220;The impact of tariffs on the energy business will be outsized since we source LFP battery cells from China,&#8221; he pointed out on the call.
Tesla&#8217;s alternative plan is to commission battery cell production in the country and search for outside-China suppliers. But Taneja conceded, &#8220;it will take time,&#8221; words not necessarily reassuring for investors eager to feed growth.
At the same time, Tesla&#8217;s brand-new <a href="https://in.benzinga.com/25/02/43519412/teslas-first-megafactory-outside-us-to-start-production-on-feb-11-report?_gl=1&#x2A;7umjf6&#x2A;_gcl_au&#x2A;OTE5OTY0NTM4LjE3NDM0MTQxMTE.&#x2A;_ga&#x2A;ZGVsZXRlZA..&#x2A;_ga_V7ZK73W7N0&#x2A;MTc0NTQzNTIyNy4xLjAuMTc0NTQzNTIyNy4wLjAuMA..">megafactory in Shanghai</a> — designed to turbocharge global energy storage manufacturing — has already hit turbulence. New tariffs have thrown a wrench into those overseas expansion plans just months after opening, potentially sidelining the company&#8217;s ambitious 50% growth projection for 2025.
And then there&#8217;s the &#8220;Elon&#8221; of all things. Musk&#8217;s polarizing political image, particularly his heightened profile in the Trump administration, has ignited vitriol — protests, boycotts, even crimes — against the brand. Sales suffered, analysts were doubtful and the company leadership&#8217;s priority seems, well, unfocused.
As Musk publicly attacks tariffs, ironically the same instrument ruining his own company&#8217;s drive into energy, one might have assumed his political stance would finally win out over criticism, and settle down to tidy up the perception mess around core customer segments.
<h1 class="wp-block-heading">What To Watch</h1>
ETF Tweaks: Will high-exposure ETFs rebalance or double down on Tesla? Monitor quarterly reshuffles and options activity.
Energy Segment Headwinds: Advancement on U.S.-based battery manufacturing and alternative suppliers will be paramount to keeping the energy segment afloat.
Geopolitical Shockwaves: Additional tariff ramp-ups or political noises surrounding China-U.S. trade could amplify risks for Tesla — and transmit through ETFs.
Elon&#8217;s Impact: Never underestimate the market-moving ability of a Musk tweet or political shift.
For investors, it&#8217;s a high-voltage waiting game. Whether Tesla recovers or ignites further volatility, one thing&#8217;s certain — the ETFs riding its fate will be anything but dull.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44962489/vix-is-still-wild-but-not-for-long-3-volatility-etfs-to-grab-before-calm-returns">VIX Is Still Wild, But Not for Long: 3 Volatility ETFs To Grab Before Calm Returns</a></li>
</ul>
Photo: Courtesy Tesla Inc.

Specialty ETFs

Global

Trading Ideas

ETFs

NITE

TESL

TSLA

Select Sector SPDR-Consumer Discretionary

Tesla's Energy Division Shines, But ETF Risks Mount Amid Broader Challenges

<a href="https://www.youtube.com/watch?v=0lVi_OBmQd4">https://www.youtube.com/watch?v=0lVi_OBmQd4</a>

Politics

Economics

General

President Trump Says Over Next Two, Three Weeks Will Set Tariff For China; Says Will Have Big Tax Breaks

Precision Drilling (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDS#NYSE">PDS</a>) reported quarterly earnings of $1.53 per share which missed the analyst consensus estimate of $1.57 by 2.55 percent. This is a 18.62 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $345.75 million which missed the analyst consensus estimate of $348.70 million by 0.84 percent. This is a 11.70 percent decrease over sales of $391.58 million the same period last year.

Precision Drilling Q1 EPS $1.53 Misses $1.57 Estimate, Sales $345.75M Miss $348.70M Estimate

Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) is looking for Q2 Adj EPS of $0.59-$0.65 vs $0.62 analyst estimate. sees sales of $1.450 billion-$1.530 billion vs $1.46 billion analyst estimate.

Guidance

Edwards Lifesciences Sees Q2 Adj EPS $0.59-$0.65 vs $0.62 Est; Sees Sales $1.450B-$1.530B vs $1.46B Est

President Trump Says Depends On China How Soon Tariffs Can Come Down

STEL

Stellar Bancorp Announces $65M Share Repurchase Program

ESSA Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESSA#NASDAQ">ESSA</a>) reported quarterly earnings of $0.29 per share. This is a 39.58 percent decrease over earnings of $0.48 per share from the same period last year. The company reported $16.23 million in sales this quarter. This is a 3.74 percent decrease over sales of $16.86 million the same period last year.

ESSA

ESSA Bancorp Q2 EPS $0.29 Down From $0.48 YoY, Sales $16.23M Down From $16.86M YoY

Northfield Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFBK#NASDAQ">NFBK</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.18 by 5.56 percent. This is a 26.67 percent increase over earnings of $0.15 per share from the same period last year.

NFBK

Northfield Bancorp Q1 EPS $0.19 Beats $0.18 Estimate

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 15 years by 8.62% on an annualized basis producing an average annual return of 19.05%. Currently, UnitedHealth Group has a market capitalization of $389.54 billion. 
Buying $100 In UNH: If an investor had bought $100 of UNH stock 15 years ago, it would be worth $1,405.91 today based on a price of $427.96 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745443826_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 15 Years

Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) is looking for Q2 Adj EPS of $1.15-$1.65 vs $2.54 analyst estimate..

Alaska Air Gr Sees Q2 Adj EPS $1.15-$1.65 vs $2.54 Est

Biotech

MLYS

Mineralys Therapeutics Reveals Publication Of Pivotal Phase 2 Advance-HTN Results In The New England Journal Of Medicine

Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.74) by 4.05 percent. This is a 16.3 percent increase over losses of $(0.92) per share from the same period last year. The company reported quarterly sales of $3.14 billion which missed the analyst consensus estimate of $3.17 billion by 1.16 percent. This is a 40.55 percent increase over sales of $2.23 billion the same period last year.

Alaska Air Gr Q1 Adj. EPS $(0.77) Misses $(0.74) Estimate, Sales $3.14B Miss $3.17B Estimate

Marvell Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) on Wednesday&nbsp;announced the successful interoperability of the&nbsp;Marvell Structera&nbsp;portfolio of Compute Express Link&nbsp;(CXL) devices&nbsp;with Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) EPYC CPUs and&nbsp;5th&nbsp;Gen Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44948063/marvell-announces-successful-interoperability-of-structera-cxl-portfolio-with-amd-epyc-cpu-and-5th" rel="noreferrer noopener">Intel Xeon platforms</a>.
The move marks Marvell&#8217;s progress towards an open and interoperable CXL ecosystem, which will address the growing demands for memory bandwidth and capacity in next-generation cloud data centers.
Marvell tapped AMD and Intel to extensively test Structera CXL products with AMD EPYC and 5th&nbsp;Gen Intel Xeon Scalable platforms across various configurations, workloads, and operating conditions.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44653936/broadcom-and-marvell-poised-for-growth-as-nvidias-cpo-push-faces-delays-analyst-reveals" rel="noreferrer noopener">Rising Tide Of AI Is So Strong That Semiconductor Optical Industry Projects $30 Billion Total Addressable Market By 2029</a>
The results demonstrated seamless interoperability, delivering stability, scalability, and high-performance memory expansion that cloud data center providers need for mass deployment.
The first-quarter&nbsp;<a target="_blank" href="https://www.benzinga.com/25/04/44852860/nvidia-lam-research-and-marvell-to-face-least-impact-from-tariffs-while-intel-and-arm-could-suffer-more-bofa-analyst'" rel="noreferrer noopener">semiconductor earnings procession</a> kicked off with&nbsp;ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) last Wednesday&nbsp;and Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) <a target="_blank" href="https://www.benzinga.com/25/04/44857887/taiwan-semiconductor-q1-surges-41-in-sales-boosted-by-ai-chip-demand-expanded-margins" rel="noreferrer noopener">on Thursday</a>.
For U.S. chip vendors,&nbsp;BofA Securities&nbsp;analysts Vivek Arya and Duksan Jang expect first-quarter results to beat as their original outlook was likely conservative and tariff-related pull-ins created a better demand environment. However, the second-quarter outlook could be in line as companies could widen the guidance range.
Marvell stock plunged over 55% year-to-date. Marvell&#8217;s <a target="_blank" href="https://www.benzinga.com/25/04/44683383/marvell-plays-ai-hardball-divestiture-sparks-155-upside-says-analyst" rel="noreferrer noopener">exit from the</a> auto space follows its October quarter restructuring, where it began shifting investments away from enterprise networking, carrier infrastructure, and automotive.
The company is now focused on AI and accelerated computing, a theme JPMorgan&#8217;s&nbsp;Harlan Sur sees as key to unlocking long-term value.
Price Action: MRVL stock closed higher by 6.22% to $53.77 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44903362/american-express-solid-revenue-and-spending-trends-drive-analyst-optimism" target="_blank" rel="noreferrer noopener">American Express&#8217; Solid Revenue, Spending Trends Drive Analyst Optimism</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Movers

Tech

ASML

INTC

MRVL

What's Going On With Marvell Technology Stock On Wednesday?

Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/25/04/b44965025/discover-financial-services-reports-first-quarter-2025-net-income-of-1-1-billion-or-4-25-per-dilut">details from the quarter.  </a>
The Details: Discover reported quarterly earnings of $4.25 per share, which beat the analyst consensus estimate of $3.39 by 25.37%. Quarterly revenue came in at $4.25 billion, which beat the analyst consensus estimate of $4.22 billion and is an increase over revenue of $4.21 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/global/25/04/44952117/apple-and-meta-fined-nearly-800-million-for-violating-european-unions-digital-markets-act?utm_source=articleShare">Apple And Meta Fined Nearly $800 Million For Violating European Union&#8217;s Digital Markets Act</a>&nbsp;
For the first quarter, Discover reported:
<ul>
<li>Digital Banking pretax income of $1.4 billion for the quarter was $316 million higher than the prior year period. </li>
<li>Total loans ended the quarter at $117.4 billion, down 7% year-over-year as a result of the student loan sale, and down 3% sequentially due to seasonal trends.</li>
<li>Net interest income for the quarter increased $71 million year-over-year, or 2%, driven by net interest margin expansion. </li>
<li>Net interest margin was 12.18%, up 115 basis points versus the prior year, benefiting from the student loan sale.</li>
<li>Non-interest income increased $15 million, or 3% from the prior year period primarily due to higher net discount and interchange revenue.</li>
<li>The total net charge-off rate was 4.99%, up seven basis points from the prior year period. Excluding the impact of the student loan sale, the net charge-off rate would have declined.</li>
<li>Provision for credit losses of $1.2 billion decreased $253 million from the prior year quarter, driven by a $190 million favorable reserve change and a $97 million decrease in net charge-offs.</li>
<li>Payment Services pretax income of $91 million was up $9 million year-over-year, or 11% primarily due to volume growth in PULSE and Diners Club as well as lower expenses.</li>
</ul>
&#8220;Discover&#8217;s solid first quarter financial performance benefited from a strong net interest margin and positive credit trends,&#8221; said Michael Shepherd, Discover&#8217;s Interim CEO. 
&#8220;These results reflect our good execution and the strength of our business model. We are pleased that Capital One has received all required approvals and look forward to completing our merger.&#8221;
The company confirmed that it expects the merger with Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) to close on or about May 18, 2025.
DFS Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Discover stock closed Wednesday up 3.63% at $176.46.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44956197/amazon-price-target-slashed-again-on-wild-card-tariff-concerns?utm_source=articleShare">Amazon Price Target Slashed Again On &#8216;Wild Card&#8217; Tariff Concerns&nbsp;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Discover Financial Reports Better-Than-Expected Q1, Expects Capital One Merger To Close In May

HOMB

Home BancShares Increased Quarterly Cash Dividend From $0.195  To $0.2

ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) is looking for Q2 GAAP EPS of $0.66-$0.78 vs $0.92 analyst estimate..

ASGN

ASGN Sees Q2 GAAP EPS $0.66-$0.78 vs $0.92 Est

IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares gained on Wednesday. The company unveiled a distribution agreement with Toyota Tsusho Corporation, marking the company&#8217;s <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44945326/ionq-signs-historic-agreement-with-toyota-tsusho-corporation-to-advance-quantum-computing-opportun" rel="noreferrer noopener">official entry into the Japanese market</a>.
The partnership, revealed during the Shanghai International Automobile Industry Exhibition, is set to fast-track the adoption of quantum computing technologies in Japan by leveraging Toyota Tsusho&#8217;s deep commercial networks and tech-forward positioning.
Niccolo de Masi, President, and CEO of IonQ, emphasized Japan&#8217;s longstanding leadership in technology and noted that the new alliance has already resulted in the company&#8217;s first contract through Toyota Tsusho&#8217;s client ecosystem.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44591436" rel="noreferrer noopener">IonQ Jumps On Amazon News, But Can It Defy Quantum Bearish Trend?</a>
&#8220;We have already signed our first local deal through Toyota Tsusho&#8217;s customer network and look forward to continuing our work in the Japanese market,&#8221; Masi said.
The collaboration is part of IonQ&#8217;s ongoing global push to expand the practical use of quantum computing solutions.
The announcement further highlights the strategic role of Toyota Tsusho, the business development arm of the Toyota Group, with an annual revenue of around $70 billion.
The firm has a track record of helping international businesses scale within Japan, and its diverse industry reach—from mobility to advanced technologies—makes it a powerful gateway for IonQ&#8217;s innovations.
Kazumi Mizukawa, General Manager of Toyota Tsusho&#8217;s Enterprise IT Department, described the agreement as a &#8220;momentous step&#8221; toward commercializing quantum computing across Japanese industries.
Over the past year, IonQ has opened the first U.S. quantum manufacturing facility, installed its first quantum computer in Europe through a partnership with QuantumBasel, and formed cooperative agreements with institutions such as AIST in Japan and the city of Busan in South Korea.
These efforts reflect IonQ&#8217;s deepening investment in the APAC region, alongside earlier partnerships with Hyundai Motors, Sungkyunkwan University, and Seoul National University.
Price Action: IONQ shares closed higher by 4.65% to $26.80&nbsp;on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44942792/tesla-q1-earnings-call-company-says-more-affordable-models-launching-this-year" target="_blank" rel="noreferrer noopener">Tesla Says More Affordable Models Launching This Year: &#8216;They Will Be Affordable And You&#8217;ll Be Able To Buy One&#8217;</a></li>
</ul>
Photo via Shutterstock

Equities

Markets

IONQ

What's Going On With IonQ Stock On Wednesday?

OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) has outperformed the market over the past 15 years by 3.55% on an annualized basis producing an average annual return of 13.98%. Currently, OSI Systems has a market capitalization of $3.25 billion. 
Buying $1000 In OSIS: If an investor had bought $1000 of OSIS stock 15 years ago, it would be worth $7,318.71 today based on a price of $193.58 for OSIS at the time of writing.
<h3>OSI Systems's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745442933_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OSIS

Here's How Much You Would Have Made Owning OSI Systems Stock In The Last 15 Years

First Quantum Minerals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FM#TSX">FM</a>) reported quarterly sales of $1.19 billion which beat the analyst consensus estimate of $1.06 billion by 12.26 percent. This is a 14.86 percent increase over sales of $1.04 billion the same period last year.

Comments

Universe Pharmaceuticals

Notizie

Ultime notizie per Universe Pharmaceuticals (NASDAQ:UPC) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO